J. Walker

发表

An endocannabinoid mechanism for stress-induced analgesia

J. Crystal, A. Hohmann, R. L. Suplita, 2005, Nature.

Identification of a New Class of Molecules, the Arachidonyl Amino Acids, and Characterization of One Member That Inhibits Pain*

J. Walker, T. Bisogno, A. Coop, 2001, The Journal of Biological Chemistry.

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

Pierangelo Geppetti, Marcello Trevisani, Abdulmonem Al-Hayani, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Regulation of anandamide tissue levels by N-arachidonylglycine.

J. Walker, Timothy J. Petros, S. Burstein, 2002, Biochemical pharmacology.

Potential anti-inflammatory actions of the elmiric (lipoamino) acids.

J. W. Shaw, H. Bradshaw, J. Walker, 2007, Bioorganic & medicinal chemistry.

Identification of Farnesyl Pyrophosphate and N-Arachidonylglycine as Endogenous Ligands for GPR92*

Min Goo Lee, H. Rhim, J. Walker, 2008, Journal of Biological Chemistry.

Dissociation of the motor effects of (+)-pentazocine from binding to σ1 sites

W. Bowen, S. L. Patrick, J. Walker, 1996 .

Regional variation in the ratio of σ1 to σ2 binding in rat brain

S. L. Patrick, A. Hohmann, J. Walker, 1994 .

A comparison of (-)-deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests role of sigma 2 receptors in motor function.

W. Bowen, S. L. Patrick, J. Walker, 1993, European journal of pharmacology.

Drug specificity of pharmacological dystonia

W. Bowen, J. Walker, K. Rice, 1990, Pharmacology Biochemistry and Behavior.

Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors.

W. Bowen, J. Walker, Eydie L. Moses, 1990, European journal of pharmacology.

Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study

W. Bowen, S. L. Patrick, A. Hohmann, 1992, Brain Research.

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist.

S. L. Patrick, J. Walker, K. Tsou, 1995, European journal of pharmacology.

Cannabinoid targets for pain therapeutics

J. Walker, Susan M. Huang, 2005 .

Endocannabinoids and related fatty acid derivatives in pain modulation.

J. F. Krey, J. Walker, Jocelyn F Krey, 2002, Chemistry and physics of lipids.

Field-free transmission geometry atmospheric pressure matrix-assisted laser desorption/ionization for rapid analysis of unadulterated tissue samples.

J. Miller, J. Walker, S. Trimpin, 2009, Rapid communications in mass spectrometry : RCM.

Automated solvent-free matrix deposition for tissue imaging by mass spectrometry.

J. Walker, E. Claude, S. Trimpin, 2010, Analytical chemistry.

Targeted lipidomics: fatty acid amides and pain modulation.

H. Bradshaw, J. F. Krey, J. Walker, 2005, Prostaglandins & other lipid mediators.

Targeted lipidomics approach for endogenous N-acyl amino acids in rat brain tissue.

J. Walker, M. F. Monn, David K. O’Dell, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Effects of U50,488H on locomotor activity in the hamster

P. Schnur, J. Walker, 1990, Pharmacology Biochemistry and Behavior.

Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior.

J. Walker, D. Ingram, A. Roman, 2007, Virology.

Structural analysis of leukotriene C4 isomers using collisional activation and 157 nm photodissociation

J. Walker, J. Reilly, David K. O’Dell, 2008, Journal of the American Society for Mass Spectrometry.

Sigma receptors: biology and function.

W. Bowen, J. Walker, K. Rice, 1990, Pharmacological reviews.

σ Binding parameters in developing rats predict behavioral efficacy of a σ ligand

W. Bowen, J. Walker, R. Matsumoto, 1993, Brain Research.

Dopamine-independent motor behavior following microinjection of rimorphin in the substantia nigra

A. Lohof, J. Walker, R. Matsumoto, 1988, Brain Research.

Anatomical and biochemical studies of the opioid peptides and related substances in the brain

H. Akil, S. Watson, J. Walker, 1980, Peptides.

Synthesis and opioid activities of stereoisomers and other D-amino acid analogs of methionine-enkephalin.

G. Berntson, C. Sandman, J. Walker, 1976, Biochemical and biophysical research communications.

Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus.

J. Walker, A. S. Miller, J. Michael Walker, 1996, European journal of pharmacology.

Identification of endogenous acyl amino acids based on a targeted lipidomics approach1[S]

J. Walker, M. F. Monn, S. Burstein, 2010, Journal of Lipid Research.

Identifi cation of endogenous acyl amino acids based on a targeted lipidomics approach 1

J. Walker, M. F. Monn, S. Burstein, 2009 .

The degradation of dynorphin A in brain tissue in vivo and in vitro

H. Akil, E. Young, R. Houghten, 1987, Peptides.

Identification of the Role of Endogenous Cannabinoids in Pain Modulation: Strategies and Pitfalls

J. Walker, N. Strangman, Susan M. Huang, 2000 .

Antinociceptive actions of cannabinoids following intraventricular administration in rats

S. L. Patrick, J. Walker, W. Martin, 1993, Brain Research.

SELECTIVITY OF BLOCKING AGENTS FOR PRE‐ AND POSTSYNAPTIC α‐ADRENOCEPTORS

J. Walker, C.F.C. Smith, J. Doxey, 1977 .

The neurobiology of cannabinoid analgesia.

A. Hohmann, J. Walker, N. Strangman, 1999, Life sciences.

Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity

S. L. Patrick, A. Hohmann, J. Walker, 1998, Brain Research.

CB1 receptor localization in rat spinal cord and roots, dorsal root ganglion, and peripheral nerve.

K. Mackie, J. Walker, N. Strangman, 1999, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

μ-Opiate binding and morphine antagonism by octapeptide analogs of somatostatin

W. Bowen, J. Walker, D. Coy, 1987, Peptides.

Induction of analgesia by central administration of ORG 2766, an analog of ACTH4--9.

H. Akil, G. Berntson, C. Sandman, 1981, European journal of pharmacology.

Effects of a metabotropic glutamate receptor 5 positive allosteric modulator, CDPPB, on spatial learning task performance in rodents

T. Schachtman, J. Walker, Á. Simonyi, 2013, Neurobiology of Learning and Memory.

Effect of ethanolamine-O-sulphate on regional GABA metabolism in the mouse brain.

J. Walker, M. Leach, 1977, Biochemical pharmacology.

Cannabinoids and pain.

J. Walker, N. Strangman, Susan M. Huang, 2001, Pain research & management.

Local effects of cannabinoids on spontaneous activity and evoked inhibition in the globus pallidus.

J. Walker, A. S. Miller, 1998, European journal of pharmacology.

Targeted lipidomics: Discovery of new fatty acyl amides

H. Bradshaw, J. F. Krey, J. Walker, 2006, The AAPS Journal.

Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol

D. McHugh, H. Bradshaw, J. Walker, 2007, Neuroscience Letters.

Regional variation in the ratio of sigma 1 to sigma 2 binding in rat brain.

S. L. Patrick, A. Hohmann, J. Walker, 1994, European journal of pharmacology.

Suppression of noxious stimulus-evoked expression of fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist

A. Hohmann, J. Walker, W. Martin, 1996, Neuroscience.

Intrathecal cannabinoid administration suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in rat spinal cord: comparison with morphine.

A. Hohmann, J. Walker, K. Tsou, 1999, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2

A. Hohmann, J. Walker, K. Tsou, 1998, Neuroscience Letters.

Endogenous opioids: biology and function.

M. E. Lewis, H. Akil, E. Young, 1984, Annual review of neuroscience.

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

K. Mackie, J. Walker, K. Mackie, 1998, Neuroscience.

Behavioral effects of dynorphin1–13 in the mouse and rat: Initial observations

H. Akil, J. Walker, R. Katz, 1980, Peptides.

Stimulation of rat striatal tyrosine hydroxylase activity following intranigral administration of sigma receptor ligands.

S. L. Patrick, J. Walker, S. Mascarella, 1995, European journal of pharmacology.

An analog of enkephalin having prolonged opiate-like effects in vivo.

G. Berntson, C. Sandman, J. Walker, 1977, Science.

Neonatal administration of beta-endorphin produces "chronic" insensitivity to thermal stimuli.

C. Berka, C. Sandman, J. Walker, 1979, Life sciences.

Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators.

H. Bradshaw, J. F. Krey, J. Walker, 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

Increase in rat striatal extracellular dopamine and vacous chewing produced by two σ receptor ligands

S. L. Patrick, J. Walker, R. Patrick, 1993 .

Iontophoretic effects of sigma ligands on rubral neurons in the rat

J. Walker, R. Matsumoto, 1992, Brain Research Bulletin.

Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons

W. Bowen, J. Walker, R. Matsumoto, 1989, Synapse.

Blockade of endogenous opiates reduces activity in the rat

G. Berntson, J. Walker, T. Paulucci, 1981, Pharmacology Biochemistry and Behavior.

Effect of naloxone on analgesia induced by food deprivation.

G. Berntson, C. Sandman, J. Walker, 1979, Life sciences.

Systemic administration of endorphins selectively alters open field behavior of rats

C. Sandman, J. Walker, A. Kastin, 1978, Physiology & Behavior.

Pain modulation by release of the endogenous cannabinoid anandamide.

J. Walker, N. Strangman, Susan M. Huang, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Effect of opiate receptor blockade on pain sensitivity in the rat

G. Berntson, J. Walker, 1977, Brain Research Bulletin.

Suppression of Noxious Stimulus-Evoked Activity in the Ventral Posterolateral Nucleus of the Thalamus by a Cannabinoid Agonist: Correlation between Electrophysiological and Antinociceptive Effects

A. Hohmann, J. Walker, W. Martin, 1996, The Journal of Neuroscience.

Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat.

J. Walker, M. Sañudo‐Peña, J. Michael Walker, 1997, Journal of neurophysiology.

Microsomal omega-hydroxylated metabolites of N-arachidonoyl dopamine are active at recombinant human TRPV1 receptors.

H. Bradshaw, J. Walker, T. Widlanski, 2009, Prostaglandins & other lipid mediators.

The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine.

H. Bradshaw, B. Cravatt, J. Walker, 2009, Prostaglandins, leukotrienes, and essential fatty acids.

The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways

H. Bradshaw, B. Cravatt, J. Walker, 2009, BMC Biochemistry.

Novel endogenous N-acyl glycines identification and characterization.

H. Bradshaw, J. Walker, N. Rimmerman, 2009, Vitamins and hormones.

Alcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals.

J. Walker, T. Hurley, David K. O’Dell, 2009, Bioorganic & medicinal chemistry letters.

N-Palmitoyl Glycine, a Novel Endogenous Lipid That Acts As a Modulator of Calcium Influx and Nitric Oxide Production in Sensory Neurons

D. McHugh, H. Bradshaw, B. Cravatt, 2008, Molecular Pharmacology.

N-Oleoyldopamine, a Novel Endogenous Capsaicin-like Lipid That Produces Hyperalgesia*

L. Petrocellis, J. Walker, T. Bisogno, 2003, The Journal of Biological Chemistry.

Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease

T. Schachtman, J. Walker, Á. Simonyi, 2011, Behavioural Brain Research.

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

Z. Vogel, D. McHugh, H. Bradshaw, 2010, BMC Neuroscience.

Activational role of cannabinoids on movement.

J. Walker, J. Fernández-Ruiz, M. Sañudo‐Peña, 2000, European journal of pharmacology.

Overexpressed Transient Receptor Potential Vanilloid 3 Ion Channels in Skin Keratinocytes Modulate Pain Sensitivity via Prostaglandin E2

M. Caterina, Hyosang Lee, H. Bradshaw, 2008, The Journal of Neuroscience.

[3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain.

J. Walker, R. Houghten, J. Woods, 1986, European journal of pharmacology.

Inhibitory effects of the κ opiate U50,488 in the substantia nigra pars reticulata

J. Walker, L. Thompson, 1990, Brain Research.

Striatonigral Prodynorphin: A Model System for Understanding Opioid Peptide Function

A. Hohmann, J. Walker, R. Matsumoto, 1990, Annals of the New York Academy of Sciences.

Effects of Dynorphin (1–8) on movement: Non-opiate effects and structure-activity relationship

J. Walker, M. W. Friederich, Douglas P. Friederich, 1987, Peptides.

Opposite effects of μ and κ opiates on the firing-rate of dopamine cells in the substantia nigra of the rat

J. Walker, L. Thompson, J. Frascella, 1987 .

The Many Possible Roles of Opioids and Related Peptides in Stress‐Induced Analgesia a

H. Akil, E. Young, S. Watson, 1986, Annals of the New York Academy of Sciences.

[D-Ala2,(F5)Phe4]-dynorphin1–13-NH2 (DAFPHEDYN): A potent analog of dynorphin 1–13

H. Akil, W. Bowen, E. Young, 1987, Peptides.

[3H] dynorphin binding to guinea pig and rat brain.

R. Houghten, J. Walker, E. Young, 1983, Life sciences.

Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.

J. Walker, Cheng Liu, Cheng Liu, 2006, Journal of neurophysiology.

Motor actions of cannabinoids in the basal ganglia output nuclei.

J. Walker, K. Tsou, M. Sañudo‐Peña, 1999, Life sciences.

Evidence for a role of haloperidol‐sensitive σ‐'opiate' receptors in the motor effects of antipsychotic drugs

W. Bowen, J. Walker, R. Matsumoto, 1988, Neurology.

CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats

J. Walker, J. Ramos, J. Fernández-Ruiz, 2008, Neuropharmacology.

Cannabinoid mechanisms of pain suppression.

A. Hohmann, J. Walker, Andrea G. Hohmann, 2005, Handbook of experimental pharmacology.

The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism – or inverse agonism – as potential obesity treatment and other therapeutic use

J. Walker, R. Raffa, S. Nagar, 2007, Journal of clinical pharmacy and therapeutics.

Opposite effects of mu and kappa opiates on the firing-rate of dopamine cells in the substantia nigra of the rat.

J. Walker, L. Thompson, J. Frascella, 1987, European journal of pharmacology.

Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.

J. Walker, R. Matsumoto, R. Patrick, 1988, The Journal of pharmacology and experimental therapeutics.

Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line

K. Mackie, H. Bradshaw, J. Walker, 2008, British journal of pharmacology.

Role of the superior colliculus in the motor effects of cannabinoids and dopamine

K. Mackie, J. Walker, K. Tsou, 2000, Brain Research.

Novel endogenous N-acyl glycines identification and characterization.

H. Bradshaw, J. Walker, N. Rimmerman, 2009, Vitamins and hormones.

Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids

C. Breivogel, S. Childers, J. Walker, 2004, Neuropharmacology.

Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation

K. Mackie, J. Walker, K. Tsou, 1999, Neuroscience.

Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat.

A. Hohmann, J. Walker, K. Tsou, 1999, Journal of neurophysiology.

Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2.

A. Hohmann, J. Walker, W. Martin, 1995, Life sciences.

An examination of the central sites of action of cannabinoid-induced antinociception in the rat.

S. L. Patrick, J. Walker, W. Martin, 1995, Life sciences.

Distribution of Endogenous Farnesyl Pyrophosphate and Four Species of Lysophosphatidic Acid in Rodent Brain

H. Bradshaw, J. Walker, Siham Raboune, 2010, International journal of molecular sciences.

Effects of intrastriatal cannabinoids on rotational behavior in rats: Interactions with the dopaminergic system

J. Walker, K. Tsou, M. Sañudo‐Peña, 1998, Synapse.

Endocannabinoids in pain modulation.

J. Walker, Susan M. Huang, S. Huang, 2002, Prostaglandins, leukotrienes, and essential fatty acids.

Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system

S. L. Patrick, J. Walker, R. Patrick, 1996, Neuroscience Letters.

Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata.

J. Walker, A. S. Miller, J. Michael Walker, 1995, European journal of pharmacology.

Inhibition of rubral neurons by noxious and non-noxious pressure

J. Walker, R. Matsumoto, 1991, Brain Research.

Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors.

W. Bowen, J. Walker, K. Rice, 1989, FEBS letters.

Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007

Yonina C. Eldar, Karl J. Friston, Leslie G. Ungerleider, 2008, Neural plasticity.

Responsesnt Facilitation of Spinal Nociceptive Cannabinoid WIN 55,212-2 Inhibits the

D. Simone, J. Walker, M. Zarrindast, 2015 .

Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses.

J. Michael Walker, J. Walker, N. Strangman, 1999, Journal of neurophysiology.

Neurons in a Rodent Model of Neuropathic Pain Effects of a Cannabinoid Agonist on Spinal Nociceptive

J. Walker, Cheng Liu, 2006 .

W. Bowen, J. Walker, R. Matsumoto, 1989, Brain Research.

Profiling of phospholipids and related lipid structures using multidimensional ion mobility spectrometry-mass spectrometry

J. Walker, Brian C. Bohrer, D. Clemmer, 2009 .

Some anatomical and physiological interactions among noradrenergic systems and opioid peptides

S. Watson, J. Walker, H. Khachaturian, 1984 .

Effects of nicotinic and muscarinic compounds on biting attack in the cat

G. Berntson, M. Beattie, J. Walker, 1976, Pharmacology Biochemistry and Behavior.

Fatty acyl amides of endogenous tetrahydroisoquinolines are active at the recombinant human TRPV1 receptor.

J. Walker, Sarah R. Pickens, N. Rimmerman, 2007, Bioorganic & medicinal chemistry.

Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla

J. Walker, W. Martin, K. Tsou, 1998, Neuroscience Letters.

Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands.

W. Bowen, C. George, J. Walker, 1989, Journal of medicinal chemistry.

Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus

S. L. Patrick, J. Walker, T. L. Thompson, 1991, Brain Research.

Cannabinoid analgesia.

J. Walker, Susan M. Huang, 2002, Pharmacology & therapeutics.

Distribution of opiate receptors within visual structures of the cat brain

S. Lehmkuhle, H. Hughes, W. Bowen, 2004, Experimental Brain Research.

Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007

Yonina C. Eldar, Karl J. Friston, Leslie G. Ungerleider, 2008, Neural plasticity.

Early perceptual loss in depression

Yonina C. Eldar, Karl J. Friston, Charles R. Seger, 2007 .

Effects of 1,3-di-o-tolylguanidine (DTG), a sigma ligand, on local cerebral glucose utilization in rat brain

S. L. Patrick, A. Hohmann, J. Walker, 1992, Brain Research.

Characterization of [3H] (+)-pentazocine, a highly selective sigma ligand.

W. Bowen, J. Walker, K. Rice, 1990, Progress in clinical and biological research.

Enhancement of spontaneous and heat-evoked activity in spinal nociceptive neurons by the endovanilloid/endocannabinoid N-arachidonoyldopamine (NADA).

J. Walker, Susan M. Huang, 2006, Journal of neurophysiology.

Effects of σ ligands on rat cerebellar purkinje neuron firing: An iontophoretic study

J. Walker, W. Martin, B. D. Costa, 1994, Brain Research Bulletin.

Abstracts of the 15th Annual Meeting of the Israel Society for Neuroscience Eilat, Israel, December 3–5, 2006

Leslie G. Ungerleider, D. Amit, H. Seung, 2006, Neural Plasticity.

Inhibition of rubral neurons by a specific ligand for σ receptors

J. Walker, R. Matsumoto, 1988 .

Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats

T. Schachtman, J. Walker, Á. Simonyi, 2011, Neurobiology of Learning and Memory.

-Arachidonoyldopamine (NADA) N Endovanilloid/Endocannabinoid Activity in Spinal Nociceptive Neurons by the Enhancement of Spontaneous and Heat-Evoked

K. Wilhelmsen, M. Schumacher, J. Walker, 2015 .

Inhibition of rubral neurons by a specific ligand for sigma receptors.

J. Walker, R. Matsumoto, 1988, European Journal of Pharmacology.

Altered haloperidol-sensitive sigma receptors in the genetically dystonic (dt) rat.

W. Bowen, J. Walker, R. Matsumoto, 1988, European journal of pharmacology.

An endocannabinoid mechanism for stress-induced analgesia

J. Crystal, A. Hohmann, R. L. Suplita, 2005, Nature.

Effects of intrapallidal cannabinoids on rotational behavior in rats: Interactions with the dopaminergic system

J. Walker, M. Sañudo‐Peña, 1998, Synapse.

Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.

W. Bowen, J. Walker, K. Rice, 1992, The Journal of pharmacology and experimental therapeutics.

Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma receptor ligands.

S. L. Patrick, J. Walker, R. Patrick, 1993, European journal of pharmacology.

A BINDS SELECTIVELY TO GUINEA PIG BRAIN

H. Akil, R. Houghten, J. Walker, 2002 .

Changes in regional glucose metabolism and behavior following intranigral application of the kappa opiate agonist U50,488

A. Hohmann, J. Walker, R. Clement, 1994, Regulatory Peptides.